VIDEO: CAR T-cell Therapy in CLL (chronic lymphocytic leukemia): Navigating the Landscape and Looking Ahead with Catherine Coombs, MD https://oncologytube.com/car-t-cell-therapy-in-cll-chronic-lymphocytic-leukemia-navigating-the-landscape-and-looking-ahead-with-catherine-coombs-md/ @UCIrvineHealth @_MDEducation @Ryan_fitzpatric
🌟Lazy Sunday Lung Cancer Quiz No 5⃣:
What was the most frequent post-progression regimen after chemo+Amivantamab in MARIPOSA-2?
#some #LCSM @OncoAlert @HeSMO_X @OncoViews
@MedscapeOnc @OncologyTimes @oncologytube @EGFRmNSCLC
Oncology Conference Videos
Oncology News
In an interview, Andrew Evens, DO, an expert in hematology and oncology, will discuss a…
In the groundbreaking study conducted by Bruce Feinberg,DO, Chief Medical Officer at Cardinal Health, the…
Hamish Scott, MD, serves as the Head of the Department of Genetics and Molecular Pathology…
Catherine Diefenbach, MD, a Hematologist and Medical Oncologist at NYU Langone Health, led a study…
By. Terry Mamounas Date: 12/07/2023In a collaborative study between NVP and RT, led by oncologist…
Allen Wilbanks finds himself at SABCS 2023, where he engages in a discussion with Dr.…
By. Ruth O’Regan MD Date: 12/07/2023In an interview, Ruth O’Regan MD addresses questions related to the…
Teclistamab FDA approval biweekly dosing in Relapsed or Refractory Multiple Myeloma (3 KOL Video Interviews…
In the realm of advancements in CAR T-cell therapy for relapsed/refractory mantle cell lymphoma (MCL),…
By. Neil Carleton, MD Date. 12/07/2023 In the interview with Neil Carleton, MD, the discussion revolved…
Evandro Bezerra, MD, hematologist and assistant professor at The Ohio State University Wexner Medical Center,…
… The Medical Oncology Association of Southern California (MOASC) 2024 Summit has once again set…